CDRE trades 51.1% below Wall Street's consensus target of $44.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CDRE achieves its forward estimates and maintains a stable P/E multiple of 25.7x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Cadre Holdings, Inc. (CDRE) has a Wall Street consensus price target of $44.33, based on estimates from 9 covering analysts. With the stock currently trading at $29.33, this represents a potential upside of +51.1%. The company has a market capitalization of $1.26B.
Analyst price targets range from a low of $40.00 to a high of $53.00, representing a 29% spread in expectations. The median target of $40.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CDRE trades at a trailing P/E of 28.8x and forward P/E of 25.7x. Analysts expect EPS to grow +34.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $30.44, with bear and bull scenarios of $19.18 and $40.10 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AXONAxon Enterprise, Inc. | $51.6B | $640.46 | $652.11 | +1.8% | Buy | 83.3x | 21 |
SWBISmith & Wesson Brands, Inc. | $671M | $15.00 | $16.50 | +10.0% | Buy | 54.5x | 4 |
AOUTAmerican Outdoor Brands, Inc. | $174M | $13.92 | $14.25 | +2.4% | Buy | 96.0x | 5 |
CODICompass Diversified | $756M | $10.05 | $15.00 | +49.3% | Hold | 35.6x | 14 |
MSAMSA Safety Incorporated | $6.6B | $170.34 | $222.33 | +30.5% | Buy | 19.2x | 11 |
AMSFAMERISAFE, Inc. | $663M | $35.45 | $44.50 | +25.5% | Buy | 16.9x | 6 |
GNSSGenasys Inc. | $76M | $1.67 | — | — | — | — | — |
TACTTransAct Technologies Incorporated | $58M | $5.61 | — | — | — | — | — |
DGLYDigital Ally, Inc. | $2M | $1.28 | — | — | — | — | — |
HONHoneywell International Inc. | $71.3B | $225.05 | $251.08 | +11.6% | Buy | 20.5x | 28 |
Quick answers to the most common questions about buying CDRE stock.
The consensus Wall Street price target for CDRE is $44.33, representing 51.1% upside from the current price of $29.33. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CDRE has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $44.33 implies 51.1% upside from current levels.
CDRE trades at a forward P/E of 25.683x, representing a moderate valuation. With analysts targeting $44.33 (51.1% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $53 for CDRE, while the most conservative target is $40. The consensus of $44.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $40 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CDRE is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CDRE stock forecast based on 9 Wall Street analysts shows a consensus price target of $44.33, with estimates ranging from $40 (bear case) to $53 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $30, with bear/bull scenarios of $19/$40.
Our quantitative valuation model calculates CDRE's fair value at $30 (base case), with a bear case of $19 and bull case of $40. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
CDRE trades at a forward P/E ratio of 25.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CDRE, with a "Buy" consensus rating and $44.33 price target (51.1% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CDRE analyst price targets range from $40 to $53, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $44.33 consensus represents the middle ground. Our model's $19-$40 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.